Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody-Reference-Cited by-同舟云学术

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

Published:2001-07 Issue:1 Volume:28 Page:47-49
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kobbe G,Schneider P,Rohr U,Fenk R,Neumann F,Aivado M,Dietze L,Kronenwett R,Hünerlitürkoglu A,Haas R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703094.pdf

Reference8 articles.

1. Shlomchik WD, Couzens MS, Bi Tang C et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells Science 1999 285: 412–415

2. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute graft-versus-host-disease: secondary treatment Blood 1991 62: 626–631

3. Przepiorka D, Kernan NA, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 2000 95: 83–89

4. Piguet PF, Grau GE, Allet B et al. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease J Exp Med 1987 166: 1280–1289

5. Scallon BJ, Moore MA, Trinh H et al. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Cytokine 1995 7: 251–259

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-way donor-to-recipient human leukocyte antigen mismatch and graft-versus-host disease in liver transplantation: an observational study of a single-center experience in Korea;Korean Journal of Transplantation;2023-11-23

2. Acute graft versus host disease after liver transplantation: where do we stand?;Minerva Surgery;2023-10

3. Treatment of steroid-refractory graft versus host disease in children;Frontiers in Transplantation;2023-09-15

4. Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study;Cancers;2023-07-13

5. Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD);Bone Marrow Transplantation;2022-11-09